Invention Grant
- Patent Title: SARS-CoV-specific B-cell epitope and applications thereof
- Patent Title (中): SARS-CoV特异性B细胞表位及其应用
-
Application No.: US10945648Application Date: 2004-09-21
-
Publication No.: US07740858B2Publication Date: 2010-06-22
- Inventor: Han-Chung Wu , I-Ju Liu , Chien-Yu Chiu
- Applicant: Han-Chung Wu , I-Ju Liu , Chien-Yu Chiu
- Applicant Address: TW
- Assignee: National Taiwan University
- Current Assignee: National Taiwan University
- Current Assignee Address: TW
- Agency: Ostrolenk Faber LLP
- Main IPC: A61K39/38
- IPC: A61K39/38 ; A61K39/12 ; A61K39/00 ; A61K39/215

Abstract:
Disclosed is SARS-CoV-specific B-cell epitope and applications thereof. The epitopes are peptides and can either be expressed in phages or synthesized to diagnose SARS patients accurately. High sensitivity and specificity of the serologic detection are achievable by using a plurality of SARS-CoV-specific B-cell epitope-based peptides. Therefore, the peptides can be applied to SARS diagnosis and have potentials to be immunogens for producing antibodies against SARS.
Public/Granted literature
- US20060062804A1 SARS-CoV-specific B-cell epitope and applications thereof Public/Granted day:2006-03-23
Information query